Healthcare Triangle, Inc. 8-KCurrent Reports (8-K / ad hoc)

Market for Equity / Stockholders

Item 5.07. Submission of Matters to a Vote of Security Holders. On July 17, 2026, at the virtual annual meeting of shareholders (the “ Annual Meeting ”), the shareholders of Healthcare Triangle, Inc. (the “ Company ”): (i) elected four (4) directors to serve a one (1) year term; (ii) ratified the appointment of SRCO Professional Corporation, Chartered Professional Accountants as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; (iii) approved a proposal to amend the 2020 Stock Incentive Plan to provide for automatic annual increases in shares reserved under the Plan; (iv) approved one or more future issuances under Nasdaq Listing Rule 5635(d); (v) approved the issuance of 2,828,167 shares of common stock pursuant to a Settlement Agreement in accordance with Nasdaq Listing Rule 5635(a); (vi) approved the issuance of securities in connection with the Teyame Transaction under Nasdaq Listing Rule 5635(a); (vii) approved the issuance of common stock in excess of the Exchange Cap pursuant to the ELOC Purchase Agreement under Nasdaq Listing Rule 5635(d); (viii) approved the issuance of common stock underlying the OID Senior Secured Convertible Debentures under Nasdaq Listing Rules 5635(b) and 5635(d); and (ix) approved the adjournment or postponement of the Annual Meeting, if necessary or appropriate, to solicit additional proxies. The proposals presented at the Annual Meeting are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A (“ Proxy Statement ”) that was filed with the Securities and Exchange Commission on June 26, 2026. Holders of 20,386,046 shares of the Company’s common stock, or approximately 92.55% of the 22,027,783 shares of common stock that were issued and outstanding and entitled to vote, were present virtually or represented by proxy at the Annual Meeting. The shares entitled to vote include the common stock of the Company and the Company’s Series A Super Voting Preferred Stock. The following are the final voting results on the proposals presented to the Company’s shareholders at the Annual Meeting. Proposal No. 1: Election of Directors The Company’s shareholders elected all of the director nominees nominated by the Board to serve for a one-year term, until the 2027 annual meeting of shareholders and until their successors are duly elected and qualified. The t